Fledrich, R., Abdelaal, T., Rasch, L., Bansal, V., Schütza, V., Brügger, B., . . . Sereda, M. W. (2018). Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications, 9, . https://doi.org/10.1038/s41467-018-05420-0
Chicago Style (17th ed.) CitationFledrich, Robert, et al. "Targeting Myelin Lipid Metabolism as a Potential Therapeutic Strategy in a Model of CMT1A Neuropathy." Nature Communications 9 (2018). https://doi.org/10.1038/s41467-018-05420-0.
MLA (9th ed.) CitationFledrich, Robert, et al. "Targeting Myelin Lipid Metabolism as a Potential Therapeutic Strategy in a Model of CMT1A Neuropathy." Nature Communications, vol. 9, 2018, https://doi.org/10.1038/s41467-018-05420-0.
Warning: These citations may not always be 100% accurate.